We are live on ! Find out more
KCM

Kingdon Capital Management Portfolio holdings

AUM $911M
1-Year Est. Return 51.11%
This Fund
S&P 500
This Quarter Est. Return
+9.53%
1 Year Est. Return
+51.11%
3 Year Est. Return
+185.44%
5 Year Est. Return
+284.29%
10 Year Est. Return
+2,022.7%
AUM
$863M
AUM Growth
-$116M
Cap. Flow
-$181M
Cap. Flow %
-20.99%
Top 10 Hldgs %
44.59%
Holding
88
New
26
Increased
10
Reduced
22
Closed
20

Sector Composition

Rank Sector Weight
1 Healthcare 19.79%
2 Technology 12.94%
3 Consumer Discretionary 11.65%
4 Communication Services 10.07%
5 Industrials 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMQ
51
Trilogy Metals
TMQ
$622M
$4.2M 0.49%
1,673,461
WNS
52
DELISTED
WNS Holdings
WNS
$4.15M 0.48%
52,000
-52,010
-50% -$3.86M
SRNG
53
DELISTED
Soaring Eagle Acquisition Corp. Class A Ordinary Share
SRNG
$4.02M 0.47%
+403,900
New +$4.04M
SE icon
54
PUT
Sea Limited
SE
$68B
$3.16M 0.37%
+11,500
New +$2.92M
MSAC
55
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
$2.9M 0.34%
+300,000
New +$2.93M
GEG icon
56
Great Elm Group
GEG
$69.3M
$2.83M 0.33%
1,259,049
VINC
57
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$2.64M 0.31%
+10,171
New +$3.1M
NAPA
58
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
$2.58M 0.3%
+117,000
New +$2.28M
EUCR
59
DELISTED
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
$1.97M 0.23%
+200,000
New +$1.97M
MMYT icon
60
CALL
MakeMyTrip
MMYT
$5.64B
$1.5M 0.17%
+50,000
New +$1.39M
DRIO icon
61
DarioHealth
DRIO
$75.6M
$1.39M 0.16%
+3,250
New +$1.24M
IFRX icon
62
InflaRx
IFRX
$252M
$1.19M 0.14%
400,000
ACET icon
63
Adicet Bio
ACET
$74.7M
$1.18M 0.14%
7,188
+938
+15% +$191K
CRC icon
64
California Resources
CRC
$4.67B
$880K 0.1%
29,199
XCUR icon
65
Exicure
XCUR
$8.48M
$509K 0.06%
2,263
RXDX
66
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$204K 0.02%
8,317
-31,683
-79% -$707K
EUCRW
67
DELISTED
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
$69K 0.01%
+66,665
New +$59.8K
MSACW
68
DELISTED
Medicus Sciences Acquisition Corp. Warrant
MSACW
$34K ﹤0.01%
+33,332
New +$26.4K
APO icon
69
Apollo Global Management
APO
$73.7B
-250,000
Closed -$11.8M
BAC icon
70
Bank of America
BAC
$441B
-300,000
Closed -$11.6M
BIDU icon
71
CALL
Baidu
BIDU
$37.1B
-25,000
Closed -$5.44M
C icon
72
Citigroup
C
$224B
-200,000
Closed -$14.6M
CARM
73
DELISTED
Carisma Therapeutics
CARM
-65,584
Closed -$3.41M
CP icon
74
Canadian Pacific Kansas City
CP
$79.4B
-176,250
Closed -$13.4M
CTSH icon
75
Cognizant
CTSH
$25.6B
-89,200
Closed -$6.97M

Similar funds

Kingdon Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Kingdon Capital Management held 88 positions worth $863M, down 12% from $979M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Kingdon Capital Management withdrew a net $181M in Q2 2021, closing 20 positions and reducing 22 holdings. Its most notable exit was Citigroup, an estimated $14.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Kingdon Capital Management opened a new position in Advanced Micro Devices worth $23.5M.

  • Kingdon Capital Management's largest Q2 2021 buy was Advanced Micro Devices: 250,000 shares worth $23.5M.
  • Kingdon Capital Management added most to Amazon in Q2 2021, an estimated $31.5M increase.
  • Kingdon Capital Management's biggest Q2 2021 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $37.3M.
  • Kingdon Capital Management fully exited Citigroup in Q2 2021, selling an estimated $14.6M.
  • Kingdon Capital Management's ten largest holdings make up 45% of its $863M portfolio in Q2 2021.
  • Kingdon Capital Management opened 26 new positions and closed 20 in Q2 2021.
  • Kingdon Capital Management's portfolio value fell 12% quarter-over-quarter to $863M.

Based on Kingdon Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.